Brighter (OM:BRIG) - Aktienkurs, Nachrichten und Analyse

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

BRIG Aktienübersicht

Brighter AB (publ), a health-tech company, develops solutions for the treatment of chronic condition in Sweden and internationally.

Über das Unternehmen

BRIG fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Belohnungen

Risikoanalyse

Shareholders have been substantially diluted in the past year

Has less than 1 year of cash runway

Earnings have declined by 42% per year over past 5 years

Does not have a meaningful market cap (SEK23M)

+ 2 mehr Risiken

Brighter AB (publ) Wettbewerber

Carbiotix

NGM:CRBX

kr9.5m

Medfield Diagnostics

NGM:MEDF

kr23.6m

Zenicor Medical Systems

NGM:ZENI

kr26.9m

Fluicell

OM:FLUI

kr32.8m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Brighter
Historical stock prices
Current Share Price	kr0.017
52 Week High	kr0.58
52 Week Low	kr0.0069
Beta	1.62
1 Month Change	-47.19%
3 Month Change	-78.33%
1 Year Change	-95.98%
3 Year Change	-99.81%
5 Year Change	-99.84%
Change since IPO	-99.47%

Aktuelle Nachrichten und Updates

Recent updates

Brighter (STO:BRIG) Share Prices Have Dropped 77% In The Last Three Years

Jan 16

Brighter (STO:BRIG) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Nov 22

Aktionärsrenditen

	BRIG	SE Medical Equipment	SE Markt
7D	-55.5%	1.5%	-0.5%
1Y	-96.0%	-7.8%	17.4%

Rendite im Vergleich zur Industrie: BRIG underperformed the Swedish Medical Equipment industry which returned -48.1% over the past year.

Rendite vs. Markt: BRIG underperformed the Swedish Market which returned -24.8% over the past year.

Preisvolatilität

Is BRIG's price volatile compared to industry and market?
BRIG volatility
BRIG Average Weekly Movement	91.4%
Medical Equipment Industry Average Movement	6.6%
Market Average Movement	5.9%
10% most volatile stocks in SE Market	12.8%
10% least volatile stocks in SE Market	3.5%

Stabiler Aktienkurs: BRIG's share price has been volatile over the past 3 months.

Volatilität im Zeitverlauf: BRIG's weekly volatility has increased from 46% to 91% over the past year.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2007	57	Erik Lissner	brighter.se

Brighter AB (publ)'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Brighter im Vergleich zum Marktanteil des Unternehmens?
BRIG grundlegende Statistiken
Marktanteil	kr23.21m
Gewinn(TTM)	-kr183.70m
Umsatz(TTM)	kr33.03m

0.7x

Kurs-Umsatz-Verhältnis

-0.1x

Kurs-Gewinn-Verhältnis

Ist BRIG zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
BRIG Gewinn- und Verlustrechnung (TTM)
Einnahmen	kr33.03m
Kosten der Einnahmen	kr10.88m
Bruttogewinn	kr22.15m
Sonstige Ausgaben	kr205.85m
Umsatz	-kr183.70m

Zuletzt gemeldete Gewinne

Jun 30, 2022

Datum des nächsten Gewinnberichts

Nov 29, 2022

Gewinn per Aktie (EPS)	-0.13
Bruttomarge	67.05%
Nettogewinnspanne	-556.20%
Schulden/Eigenkapital-Verhältnis	1.7%

Wie hat sich BRIG auf lange Sicht entwickelt?

Historische Performance und Vergleiche

This company listing is no longer active

BRIG Aktienübersicht

Belohnungen

Risikoanalyse

Brighter AB (publ) Wettbewerber

NGM:CRBX

kr9.5m

NGM:MEDF

kr23.6m

NGM:ZENI

kr26.9m

OM:FLUI

kr32.8m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Nasdaq Stockholm AB Decides to Delist the Shares and Equity Rights of Brighter AB

Nasdaq Stockholm imposes a fine on Brighter AB (publ)

Brighter AB (Publ) Applies for Corporate Restructuring in Bid for Longer-Term Financing

Brighter AB (publ) Announces Executive Changes

Brighter AB (publ) to Report Fiscal Year 2022 Results on Apr 13, 2023

Second quarter 2022 earnings released: kr0.05 loss per share (vs kr0.21 loss in 2Q 2021)

Recent updates

Nasdaq Stockholm AB Decides to Delist the Shares and Equity Rights of Brighter AB

Nasdaq Stockholm imposes a fine on Brighter AB (publ)

Brighter AB (Publ) Applies for Corporate Restructuring in Bid for Longer-Term Financing

Brighter AB (publ) Announces Executive Changes

Brighter AB (publ) to Report Fiscal Year 2022 Results on Apr 13, 2023

Second quarter 2022 earnings released: kr0.05 loss per share (vs kr0.21 loss in 2Q 2021)

Brighter AB (Publ.) Announces its Actiste® Receives Telecommunication Type Approval in the United Arab Emirates

High number of new and inexperienced directors

Brighter AB (publ) Receives Final Approvals for Pilot Research with Insulin-Treated Diabetes Patients in the UAE

High number of new and inexperienced directors

Brighter's Interim CEO Erik Lissner Takes Permanent Role as the Company CEO

Brighter AB Announces Actiste®, for the First Time, Is Prescribed to A Patient Living with Diabetes in Qatar

700Brighter AB Announces Actiste, for the First Time, Is Prescribed to A Patient Living with Diabetes in Qatar

Brighter AB (Publ) Announces Appointment of Johnny Ludvigsson as Board Member

Brighter AB (publ) Announces First Patient Recruited for the Actiste Study in the United Kingdom

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new and inexperienced directors

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Brighter AB (Publ) Announces Launch and Commercial Availability of its Actiste® Service, Aiming to Improve the Quality of Life for People Living with Diabetes in Qatar

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Brighter AB (publ) to Report Fiscal Year 2021 Results on Apr 13, 2022

Brighter AB (publ) to Report Q3, 2022 Results on Nov 09, 2022

Brighter AB (publ), Annual General Meeting, May 05, 2022

Brighter AB (publ) has completed a Composite Units Offering in the amount of SEK 117.093404 million.

Brighter AB (publ) announces positive results for Actiste®

A shareholder of Blodtrycksdoktorn AB entered into an agreement to acquire an unknown stake in Blodtrycksdoktorn AB from Brighter AB (publ) (OM:BRIG) for SEK 5 million.

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

Third quarter 2021 earnings released: kr0.20 loss per share (vs kr0.18 loss in 3Q 2020)

Brighter's Actiste Receives Final Outstanding Approval in Qatar

Interim Chief Financial Officer Julie Silber has left the company

Second quarter 2021 earnings released: kr0.20 loss per share (vs kr0.27 loss in 2Q 2020)

Brighter's Actiste Receives Telecommunication Approval in Qatar

Brighter's Actiste Mini Receives Telecommunication Approval in Qatar

Compatibility with New Insulins Opens Up New Market Opportunities for Brighter's Actiste

Brighter AB (Publ) Launches Innovative Pilot Project with Tomelilla Municipality

Brighter AB (Publ) Provides Revenue Guidance for the Year 2021

Brighter AB (Publ) Makes Progress with the User Experience Test of the Diabetes Management Solution Actiste

First quarter 2021 earnings released: kr0.20 loss per share (vs kr0.19 loss in 1Q 2020)

Brighter AB (Publ) Announces the Patent to Safely Combine MDD and IVDD Functionality into One Unit

Revenue and earnings beat expectations

Full year 2020 earnings released: kr1.04 loss per share (vs kr1.06 loss in FY 2019)

Brighter AB (publ) to Report Q4, 2021 Results on Feb 20, 2022

Brighter Signs 5-Year Distribution Agreement for Actiste in Qatar

New 90-day low: kr1.31

Brighter AB (publ) Announces CEO Changes

New 90-day low: kr1.60

Brighter (STO:BRIG) Share Prices Have Dropped 77% In The Last Three Years

Brighter AB (publ) Announces Diabetes Management Devices Actiste and Actiste Mini Receives Market Approval in Thailand

Brighter AB (publ) Announces Clarification of Information Regarding Agreements for Nigeria and Ghana

Brighter AB (publ) Signs 5-Year Agreement with Wssonlines Nigeria Ltd and Receives Initial Order for Actiste® Worth Eur 2.3 Million in Nigeria

New 90-day low: kr2.15

Brighter AB (publ)'s Actiste® Mini Receives Market Approval in the Kingdom of Saudi Arabia

Brighter AB (Publ) Announces Nomination Committee for the AGM 2021

Brighter (STO:BRIG) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Brighter AB (publ) Announces Executive Changes

New 90-day high: kr3.50

Brighter's Pioneering Diabetes Management Solution Actiste® Receives Market Approval in the United Arab Emirates

Third quarter 2020 earnings released: kr0.16 loss per share

Erträge & Einnahmen